| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |